AI Could Cure Cancer
Economy, Sci & Tech

AI Could Cure Cancer

A new research document released in the US suggests with the help of artificial intelligence cancer could quickly become a disease of the past.
Scientists at the Pharmaceutical Artificial Intelligence (pharma.AI) Group, announced the publication of a paper demonstrating the application of generative adversarial autoencoders (AAEs) to generating new molecular fingerprints on demand.
Generative adversarial autoencoders are a relatively new branch of unsupervised machine learning, implemented by a system of two neural networks competing against each other in a zero-sum game framework.
In layman’s terms, the scientists have developed a way to target cancer in a more direct way than before.  
The study was published in US’ Oncotarget on December 22. It represents the proof of concept for applying Generative Adversarial Networks (GANs) to drug discovery, Eureka Alert reports.
The scientists now plan to launch a comprehensive drug discovery engine producing promising therapeutic treatments to significantly accelerate pharmaceutical R&D and improve the success rates in clinical trials.
Since 2010 deep learning systems demonstrated results in image, voice and text recognition, in many cases surpassing human accuracy and enabling autonomous driving, automated creation of art and even composition of music.
In recent years GANs produced extraordinary results in generating meaningful images according to the desired descriptions.
The new paper represents a proof of concept of an artificially-intelligent drug discovery engine, where computers are used to produce new molecular fingerprints with the desired molecular properties.
Earlier this year the pharmaceutical artificial intelligence division at the same company published several proofs of concept papers demonstrating the applications of deep learning to drug discovery, biomarker development, and aging research.
“Generative AAE is a radically new way to discover drugs according to the required parameters, adding “we use this pipeline to uncover the prospective uses of molecules, where these types of data are available,” said Alex Aliper, president, European R&D at the Pharma.AI group of Insilico Medicine.


Short URL : https://goo.gl/j8hIuw
  1. https://goo.gl/p781Vt
  • https://goo.gl/xfPGyU
  • https://goo.gl/rPPd5j
  • https://goo.gl/zORljQ
  • https://goo.gl/rjsfai

You can also read ...

How China Became Iran’s Coziest Trade Partner?
From bilateral trade to finance contracts and civil projects,...
The economy of the Islamic Republic of Iran has been tied to political and foreign affairs developments over the years.
This is the Financial Tribune’s last edition of the current...
Iranian Banking Sector Awaits Full JCPOA Benefits
Iran’s Deputy Foreign Minister Abbas Araqchi addressed various...
President Hassan Rouhani on Sunday spoke to reporters after the last Cabinet meeting of the current year.
President Hassan Rouhani on Sunday outlined his administration...
Iran has more than 37 billion tons of proven mineral reserves and 57 billion tons of potential reserves.
Iran exported more than 58.09 million tons of mineral products...
All-Out Growth in Interbank Market
The Central Bank of Iran has released its latest data on the...

Add new comment

Read our comment policy before posting your viewpoints